Admin

Egypt’s Eva Pharma granted licence to manufacture, distribute Gilead’s COVID-19 drug remdesivir in 127 countries

Egypt’s Eva Pharma granted licence to manufacture, distribute Gilead’s COVID-19 drug remdesivir in 127 countries

Eva Pharma will become the first company to sell Gilead’s COVID-19 drug remdesivir in Egypt Egyptian drugmaker Eva Pharma said it had reached a “landmark” deal with Gilead Sciences Inc to become the licensed manufacturer of the US company’s antiviral treatment...

You will travel after COVID19, but it won’t be the same

You will travel after COVID19, but it won’t be the same

By Avi Meir, TravelPerk Co-founder & CEO The Coronavirus pandemic has changed all of our worlds, and not just in the short-term. Outside of healthcare—where heroes dressed in gowns are battling on the front lines—few industries have been hit like travel. In my...

Australian clot-busting drug holds hope for COVID-19 treatment

Australian clot-busting drug holds hope for COVID-19 treatment

FILE PHOTO: A nurse checks a patient’s temperature in a coronavirus disease (COVID-19) testing clinic at Westmead Hospital in Sydney, Australia, May 12, 2020. REUTERS/Loren Elliott SYDNEY (Reuters) – An experimental drug developed by an Australian...

Experimental coronavirus vaccine reaches advanced trial stages

Experimental coronavirus vaccine reaches advanced trial stages

LONDON ⁠— An experimental vaccine forCOVID-19 under development at Oxford University hit a milestone Friday with researchers announcing it will be progressing to advanced stages of human trials. t will be tested in 10,260 volunteers across the United Kingdom to...

How Smart City Planning Could Slow Future Pandemics

How Smart City Planning Could Slow Future Pandemics

The Covid-19 crisis is an opportunity to rethink how cities are designed—and make them better equipped to stop disease from spreading. THE CITIES OF the world are sick. As the coronavirus pandemic continues, people living in metropolitan areas have been among the...

تواصل مع فريق المدونة

للنشر